NeoGenomics, Inc. NEO 深 滬
已收盤 02-06 16:00:00 美东时间
11.42
+0.150
+1.33%
華盛通- 最 高11.58
- 今 開11.43
- 成交量 240.64万股
- 最 低 11.16
- 昨 收 11.27
- 總市值 14.78亿
- 52周最高 13.74
- 市盈率 靜 --
- 換手率 1.86%
- 52周最低 4.72
- 委 比 40.58%
- 總股本 1.29亿
- 歷史最高 61.57
- 量 比 1.90
- 振 幅 3.73%
- 歷史最低 0.96
- 每 手 1
- 風險率 2.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Needham Reiterates Buy on NeoGenomics, Maintains $14 Price Target
Needham analyst Mike Matson reiterates NeoGenomics (NASDAQ:NEO) with a Buy and maintains $14 price target.
01-12 23:32
NeoGenomics Sees Q4 Sales $190.000M vs $188.260M Est
NeoGenomics (NASDAQ:NEO) sees Q4 sales of $190.000 million vs $188.260 million analyst estimate.
01-12 20:10
Ryvyl, NeoGenomics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mostly flat this morning, with the Dow futures gaining ...
2025-12-30 21:03
NeoGenomics Announces Board Changes to Support Future Growth
NeoGenomics ( ($NEO) ) has shared an announcement. On December 23, 2025, NeoGen...
2025-12-30 20:27
Natera Ends Lawsuit, Clearing Path for NeoGenomics' RaDaR ST Launch
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that Natera voluntarily dismissed its appeal (and NeoGenomics thus dismissed its
2025-12-15 20:24
NeoGenomics Data At ASH 2025 Shows Comprehensive Genomic Profiling Improves Diagnosis And Identifies Actionable Fusions In Myeloid Malignancies
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will present new data demonstrating how comprehensive genomic profiling (CGP) can refine diagnosis and
2025-12-08 21:08
Natera Buys Foresight To Boost Super-Early Cancer Detection Tech
Natera acquires Foresight Diagnostics for $275 million upfront with potential for $175 million in earnouts.
2025-12-05 23:05
Earnings Scheduled For November 14, 2025
Companies Reporting Before The Bell • Inhibrx Biosciences (NASDAQ:INBX) is expe...
2025-11-14 19:11
